セッション情報

FACO Poster Session

第56回・2018年・横浜
FACO Poster Session
FACO Poster Session 1
FACO Poster Session 1
開催回
第56回・2018年・横浜

演題取り下げ

演題番号 : FP1-1

演題取り下げ

演題取り下げ

演題番号 : FP1-2

演題取り下げ

The dynamic changes of the epithelial and mesenchymal composition of circulating tumor cells in breast cancer patients treated with Neo-adjuvant Chemotherapy

演題番号 : FP1-3

Speaker)Zhao Liu:1、Yi Zhao:2、Xiaoming Zha:2、Xiaoan Liu:2、Tiansong Xia:2、Wenbin Zhou:2、Jue Wang:2、Zhenghui Wang:2、Shui Wang:2

1:Departement of Thyroid and Breast Surgery, The Affiliated Hospital of Xuzhou Medical University, China、2:Shandong Cancer Hospital Affiliated to Shandong University, China

The dynamic changes of the epithelial and mesenchymal composition of circulating tumor cells in breast cancer patients treated with Neo-adjuvant Chemotherapy

Preparation and evaluation study of Cy754-Rituximab: A new receptor-targeted tracer for sentinel lymph node in animal model

演題番号 : FP1-4

Speaker)Binbin Cong:1、Xiaoshan Cao:1、Yongsheng Wang:1、Jinming Yu:2

1:Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, China、2:Department of Radiation Oncology, Institut Curie, France

Preparation and evaluation study of Cy754-Rituximab: A new receptor-targeted tracer for sentinel lymph node in animal model

The study of lymphatic drainage pattern of internal mammary sentinel lymph node in breast

演題番号 : FP1-5

Speaker)Xiaoshan Cao:1、Binbin Cong:1、Yongsheng Wang:1

1:Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, China

The study of lymphatic drainage pattern of internal mammary sentinel lymph node in breast

Identification and integrated analysis of differentially expressed CircRNAs reveal a potential Hsa_circ_0087378-miR-1260b-SFRP1 regulatory axis in ER-positive subtype breast cancer

演題番号 : FP1-6

Speaker)Chenwei Yuan:1、Liheng Zhou:1、Lei Zhang:1、Kai Yin:1、Jing Peng:1、Rui Sha:1、Shan Zhang:1、Yaqian Xu:1、Yaohui Wang:1、Yanping Lin:1、Shuguang Xu:1、Wenjin Yin:1、Jinsong Lu:1

1:Department of Breast Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, China

Identification and integrated analysis of differentially expressed CircRNAs reveal a potential Hsa_circ_0087378-miR-1260b-SFRP1 regulatory axis in ER-positive subtype breast cancer

Discussion on indications of internal mammary sentinel lymph node biopsy in breast cancer in the era of precision medicine

演題番号 : FP1-7

Speaker)Pengfei Qiu:1、Yongsheng Wang:1、Yanbing Liu:1、Peng Chen:1、Tong Zhao:1、Chunjian Wang:1、Zhaopeng Zhang:1、Xiao Sun:1

1:Breast Cancer Center, Shandong Cancer Hospital Affiliated to Shandong University, China

Discussion on indications of internal mammary sentinel lymph node biopsy in breast cancer in the era of precision medicine

演題取り下げ

演題番号 : FP1-8

演題取り下げ

演題取り下げ

演題番号 : FP1-9

演題取り下げ

演題取り下げ

演題番号 : FP1-10

演題取り下げ

演題取り下げ

演題番号 : FP1-11

演題取り下げ

A small percentage of primary breast cancer shows high tumor mutation burden and may benefit from immune checkpoint inhibitor therapy

演題番号 : FP1-12

Speaker)Jingshu Wang:1、Wei Chen:2、Zhimin Jiang:1、Xiangan Lin:1、Tao Qin:1、Xing Yang:1、Tianhao Liu:1、Hai Hu:1、Zhihua Li:1、Derong Xie:1、Herui Yao:1

1:Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, China、2:Department of Gastrointestinal Colorectal and Anal Surgery, China- Japan Union Hospital of Jilin University, China

A small percentage of primary breast cancer shows high tumor mutation burden and may benefit from immune checkpoint inhibitor therapy

演題取り下げ

演題番号 : FP1-13

演題取り下げ

演題取り下げ

演題番号 : FP1-14

演題取り下げ

演題取り下げ

演題番号 : FP1-15

演題取り下げ

M-phase phosphoprotein 8 promotes gastric cancer growth and metastasis via p53/Bcl-2 and EMT-related signalling pathways

演題番号 : FP1-16

Speaker)Yizhuo Wang:1、Huijie Xiao:2、Chang Wang:1、Haitao Wu:1、Hua He:1、Cheng Yao:1、Jiuwei Cui:1、Li Wei:1

1:Department of Cancer Center, First Hospital of Jilin University, China、2:Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, China

M-phase phosphoprotein 8 promotes gastric cancer growth and metastasis via p53/Bcl-2 and EMT-related signalling pathways

Efficacy of adjuvant chemotherapy regimens with or without oxaliplatin in intestinal and diffuse type pathological stage III gastric cancer after D2 gastrectomy

演題番号 : FP1-17

Speaker)Xi Cheng:1、Yuehong Cui:1、Yan Wang:1、Tianshu Liu:1

1:Department of Medical Oncology, Zhongshan Hospital Fudan University, China

Efficacy of adjuvant chemotherapy regimens with or without oxaliplatin in intestinal and diffuse type pathological stage III gastric cancer after D2 gastrectomy

演題取り下げ

演題番号 : FP1-18

演題取り下げ

演題取り下げ

演題番号 : FP1-19

演題取り下げ

演題取り下げ

演題番号 : FP1-20

演題取り下げ

演題取り下げ

演題番号 : FP1-21

演題取り下げ

演題取り下げ

演題番号 : FP1-22

演題取り下げ

演題取り下げ

演題番号 : FP1-23

演題取り下げ

演題取り下げ

演題番号 : FP1-24

演題取り下げ

演題取り下げ

演題番号 : FP1-25

演題取り下げ

Radiofrequency ablation versus laparoscopic hepatectomy for hepatocellular carcinoma:a propensity score matching study

演題番号 : FP1-26

Speaker)Yangxun Pan:1、Minjiang Yi:1、Jinbin Chen:1、Juncheng Wang:1、Yaojun Zhang:1、Li Xu:1、Minshan Chen:1、Zhongguo Zhou:1

1:Department of Hepatobiliary & Pancreatic Surgery, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, China

Radiofrequency ablation versus laparoscopic hepatectomy for hepatocellular carcinoma:a propensity score matching study

演題取り下げ

演題番号 : FP1-27

演題取り下げ

USP10 suppresses tumor progression by stabilizing PTEN and AMPKa in hepatocellular carcinoma cells

演題番号 : FP1-28

Speaker)Chang Lu:1,2、Zhen Ning:1,2、Aman Wang:3、Di Chen:2、Guang Tan:1、Hailong Piao:2

1:Department of Hepatobiliary Surgery, 1st Affliated Hospital of Dalian Medical University, China、2:scientific reasearch center for translational medicine, Dalian Institute of Chemical Physics Chinese Academy of Sciences, China、3:Oncology Department, 1st Affliated Hospital of Dalian Medical University, China

USP10 suppresses tumor progression by stabilizing PTEN and AMPKa in hepatocellular carcinoma cells

演題取り下げ

演題番号 : FP1-29

演題取り下げ

演題取り下げ

演題番号 : FP1-30

演題取り下げ

演題取り下げ

演題番号 : FP1-31

演題取り下げ

演題取り下げ

演題番号 : FP1-32

演題取り下げ

演題取り下げ

演題番号 : FP1-33

演題取り下げ

演題取り下げ

演題番号 : FP1-34

演題取り下げ